Ocugen (OCGN) EBIAT (2016 - 2025)
Ocugen (OCGN) has disclosed EBIAT for 12 consecutive years, with -$17.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT fell 27.34% year-over-year to -$17.7 million, compared with a TTM value of -$67.8 million through Dec 2025, down 25.31%, and an annual FY2025 reading of -$67.8 million, down 25.32% over the prior year.
- EBIAT was -$17.7 million for Q4 2025 at Ocugen, up from -$20.0 million in the prior quarter.
- Across five years, EBIAT topped out at -$7.1 million in Q1 2021 and bottomed at -$26.0 million in Q2 2021.
- Average EBIAT over 5 years is -$16.3 million, with a median of -$15.3 million recorded in 2024.
- The sharpest move saw EBIAT tumbled 618.1% in 2021, then soared 56.8% in 2023.
- Year by year, EBIAT stood at -$14.6 million in 2021, then crashed by 50.1% to -$21.9 million in 2022, then skyrocketed by 56.8% to -$9.5 million in 2023, then plummeted by 46.66% to -$13.9 million in 2024, then fell by 27.34% to -$17.7 million in 2025.
- Business Quant data shows EBIAT for OCGN at -$17.7 million in Q4 2025, -$20.0 million in Q3 2025, and -$14.7 million in Q2 2025.